About Idera

• Overview
• Letter to Stockholders
• History and Vision
• Management Team
• Board of Directors
• Advisors
  • Hepatitis C Clinical Advisory Board
  • Autoimmune Disease Scientific Advisory Board
• Corporate Governance

Development

• Pipeline Chart
• IMO-2055
• IMO-2125
• IMO-2134
• IMO-3100

Research

• Overview
• Chemistry of Nucleic Acid Therapeutics
• About Toll-like Receptors
• Overview of Human Immune System
• TLR Agonists
  • TLR 9 Agonists
  • TLR7/TLR8 Agonists
  • TLR7, 8, and 9 Agonists as Vaccine Adjuvants
• TLR Antagonists
• TLR Antisense
• Scientific Publications
• Intellectual Property
  • TLR Agonists / Antagonists Patent Portfolio
  • Antisense Patent Portfolio

Collaborators

• Overview
• Merck Sharp & Dohme Corp.
• Merck KGaA
• Academic and Research Collaborations

Investors

• Overview
• Corporate Governance
• Board of Directors
• Stock Information
• Financial Reports
• SEC Filings
• Fundamentals
• FAQs
• Analyst Information
• Investor Kit
• IR Contact

Media

• Event Calendar
• Webcasts & Presentations
• News
• Information Request
• Email Alerts
• Media Contact

Careers

• Job Opportunities

Contact Info and Directions

Terms of Use